Johanna Röstin
General Counsel at VIVESTO AB
Johanna Röstin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIVESTO AB | General Counsel | 2021-09-30 | - |
Career history of Johanna Röstin
Former positions of Johanna Röstin
| Companies | Position | Start | End |
|---|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | General Counsel | - | - |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | General Counsel | - | - |
Training of Johanna Röstin
| Royal Institute of Technology | Graduate Degree |
Statistics
International
| Sweden | 5 |
Operational
| General Counsel | 3 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| VIVESTO AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private companies | 1 |
|---|---|
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Johanna Röstin
- Experience
